Appointment of Mr. Vivek Mohan (DIN : 00075006) as Additional (Non-Executive) Director with effect from January 1, 2026.
ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Abbott India has informed the stock exchange of a board-level transition. Mr. Ambati Venu has resigned as Director of the company, effective close of business hours on December 31, 2025, to pursue an external career opportunity. To fill the vacancy, the Board has appointed Mr. Vivek Mohan (DIN: 00075006) as an Additional (Non-Executive) Director with effect from January 1, 2026, subject to shareholder approval via postal ballot. Mr. Mohan is a long-tenured Abbott executive who joined the group in 1992, and is concurrently taking on the role of Vice President, Established Pharmaceuticals, India. He has previously held senior leadership roles across the US, UK, India, Indonesia, and the Middle East, including a prior stint as Managing Director of Abbott India's EPD division.
A routine, well-managed leadership transition with an internal Abbott appointee who already knows the India business well — likely neutral for shareholders, with continuity expected in strategy and operations.